With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating ...
Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors ...
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions ...
Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities ...
McKesson MCK has started 2025 on a positive ... and effectively execute cost-saving initiatives in segments like Medical-Surgical Solutions. MCK and the Medical – Dental Supplies industry ...
especially in specialty products and GLP-1 medications, as well as contributions from Prescription Technology Solutions and Medical-Surgical Solutions. Furthermore, McKesson raised its fiscal 2025 ...
Vitalone confirmed the company raised its adjusted EPS guidance to a range of $32.55 to $32.95 for fiscal 2025, representing 19%-20% year-over-year growth. Management raised full-year guidance for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results